A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

被引:0
作者
P Vahteristo
H Eerola
A Tamminen
C Blomqvist
H Nevanlinna
机构
[1] Helsinki University Central Hospital,Department of Obstetrics and Gynaecology
[2] Helsinki University Central Hospital,Department of Oncology
[3] Uppsala University Hospital,Department of Oncology
来源
British Journal of Cancer | 2001年 / 84卷
关键词
breast cancer; ovarian cancer; mutation; probability model;
D O I
暂无
中图分类号
学科分类号
摘要
Germline mutations in BRCA1 and BRCA2 genes predispose to hereditary breast and ovarian cancer. Our aim was to find associations between the clinical characteristics and positive mutation status in 148 breast cancer families in order to predict the probability of finding a BRCA mutation in a family. Several factors were associated with mutations in univariate analysis, whereas in multivariate analysis (logistic regression with backward selection) only the age of the youngest breast cancer patient and the number of ovarian cancer cases in a family were independent predictors of BRCA mutations. A logistic model was devised to estimate the probability for a family of harbouring a mutation in either BRCA1 or BRCA2. Altogether, 63 out of 148 families (43%) and 28 out of 29 (97%) mutation carrier families obtained probabilities over 10%. The mean probability was 55% for mutation-positive families and 11% for mutation-negative families. The models by Couch et al (1997) and Shattuck-Eidens et al (1997) previously designed for BRCA1 were also tested for their applicability to distinguish carrier families with mutations in either gene. The probability model should be a useful tool in genetic counselling and focusing the mutation analyses, and thus increasing also the cost-effectiveness of the genetic screening. © 2001 Cancer Research Campaign
引用
收藏
页码:704 / 708
页数:4
相关论文
共 405 条
  • [1] Berry DA(1997)Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history J Natl Cancer Inst 89 227-238
  • [2] Parmigiani G(1999)Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC demonstration project on familial breast cancer Disease Markers 15 53-65
  • [3] Sanchez J(1997)BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer N Engl J Med 336 1409-1415
  • [4] Schildkraut J(2000)Familial breast cancer in southern Finland: How prevalent are breast cancer families and can we trust the family history reported by the patient? Eur J Cancer 36 1143-1148
  • [5] Winer E(1998)Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients Am J Hum Genet 63 45-51
  • [6] Chang-Claude J(1998)Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families Am J Hum Genet 62 676-689
  • [7] Becher H(1999)The importance of a family history of breast cancer in predicting the presence of a BRCA mutation Am J Hum Genet 65 1776-1779
  • [8] Caligo M(1995)Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families Am J Hum Genet 57 1284-1297
  • [9] Eccles D(1997)Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene Nat Genet 15 103-105
  • [10] Evans G(1999)High frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects J Med Genet 36 304-308